Related Experiment Video

Updated: Jun 19, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Day 1 blood glucose and outcome in critically ill children

Rakesh Lodha, Tsultem D Bhutia, S K Kabra

    Indian Pediatrics
    |October 9, 2009
    PubMed

    Insights

    In critically ill children, day 1 hypoglycemia after PICU admission was linked to increased mortality. This finding challenges the common belief that hyperglycemia is the primary glucose-related risk factor in pediatric intensive care.

    Area of Science:

    • Pediatric Critical Care Medicine
    • Endocrinology
    • Clinical Biochemistry

    Background:

    • Assessing the impact of glucose dysregulation on pediatric intensive care unit (PICU) outcomes is crucial.
    • Day 1 glucose levels are an early indicator of metabolic status in critically ill children.
    • Understanding glucose-PICU outcome associations can inform clinical management strategies.

    Discussion:

    • The study observed a higher mortality rate in children with day 1 hypoglycemia compared to those with normal glucose levels.
    • Hyperglycemia was present in a significant portion of pediatric ICU admissions (27.7%), but its association with mortality was not as strong as hypoglycemia in this cohort.
    • These findings contrast with established literature often highlighting hyperglycemia as a predictor of poor outcomes in critically ill adults and children.

    Key Insights:

    • Day 1 hypoglycemia is a significant predictor of mortality in pediatric intensive care.
    • The association between hypoglycemia and mortality in critically ill children warrants further investigation.
    • Clinical vigilance for hypoglycemia in pediatric ICU patients may be as critical as for hyperglycemia.

    Outlook:

    • Further research is needed to elucidate the mechanisms linking hypoglycemia to mortality in this population.
    • Investigating targeted interventions for hypoglycemia in pediatric critical care may improve patient outcomes.
    • Comparative studies examining glucose variability and different glycemic thresholds are recommended.

    More Related Videos

    Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice11:10

    Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

    Published on: November 16, 2011

    Related Concept Videos

    Diabetic Ketoacidosis l: Introduction01:25

    Diabetic Ketoacidosis l: Introduction

    DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
    Hyperglycemia01:29

    Hyperglycemia

    Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
    Hypoglycemia01:26

    Hypoglycemia

    Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
    Diabetes: Symptoms, Diagnosis, and Complications01:15

    Diabetes: Symptoms, Diagnosis, and Complications

    For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
    Type I Diabetes III: Clinical Manifestations01:19

    Type I Diabetes III: Clinical Manifestations

    Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...